CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 89 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67,163,577 | +84.9% | 1,748,141 | +11.4% | 3.59% | +134.1% |
| Q1 2023 | $36,317,651 | -4.1% | 1,568,797 | +8.6% | 1.53% | -3.5% |
| Q4 2022 | $37,854,546 | +38.5% | 1,444,830 | +3.9% | 1.59% | +40.1% |
| Q3 2022 | $27,327,000 | -12.4% | 1,390,000 | -22.1% | 1.14% | -4.4% |
| Q2 2022 | $31,206,000 | +33.0% | 1,784,200 | +24.4% | 1.19% | +65.6% |
| Q1 2022 | $23,464,000 | +15.3% | 1,434,200 | +15.0% | 0.72% | +82.0% |
| Q4 2021 | $20,346,000 | +52.2% | 1,247,468 | +19.1% | 0.39% | +75.1% |
| Q3 2021 | $13,366,000 | -2.2% | 1,047,468 | +8.2% | 0.22% | +10.3% |
| Q2 2021 | $13,668,000 | +60.0% | 968,023 | +76.1% | 0.20% | +61.9% |
| Q1 2021 | $8,541,000 | +2.3% | 549,615 | +4.4% | 0.13% | +5.9% |
| Q4 2020 | $8,350,000 | – | 526,455 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |